Al's Comment:

 This looks promising. Still too early to tell, but early results look good.

---

Posted on: 02/08/2024

Biodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in Recurrent Glioblastoma Patients

 

---

Click HERE to return to brain tumor news headlines.